Inventor · disambiguated record
Glenn Pilkington
Also filed as: PILKINGTON GLENN · PILKINGTON GLENN R · PILKINGTON GLENN RONALD
10 granted patents·13 pending applications·234 citations·filing 2003–2014
91Inventor score
Top patents by PatentIndex Score
23 records- 0194US7619068B2Ovr110 antibody compositions and methods of useDIADEXUS INC·Filed 2004·Granted Nov 17, 2009·82 cites·148 claims
- 0292US7294704B2Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer riskDIADEXUS INC·Filed 2004·Granted Nov 13, 2007·40 cites·32 claims
- 0391US8221759B2Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2011·Granted Jul 17, 2012·19 cites·1 claims
- 0491US8080650B2Pro104 antibody compositions and methods of usePAPKOFF JACKIE·Filed 2009·Granted Dec 20, 2011·35 cites·12 claims
- 0591US7488477B2Neutralizing monoclonal antibodies to respiratory syncytial virusINTRACEL RESOURCES LLC·Filed 2003·Granted Feb 10, 2009·37 cites·1 claims
- 0690US8835609B2Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereofBARDEN JULIAN ALEXANDER·Filed 2010·Granted Sep 16, 2014·14 cites·10 claims
- 0779US9428587B2Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereofBIOSCEPTRE INT LTD·Filed 2014·Granted Aug 30, 2016·3 cites·13 claims
- 0869US7479546B2Pro104 antibody compositions and methods of useDIADEXUS INC·Filed 2004·Granted Jan 20, 2009·2 cites·62 claims
- 0968US8148093B2Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer riskSIMON IRIS·Filed 2007·Granted Apr 3, 2012·1 cites·51 claims
- 1067US2009110684A1Neutralizing monoclonal antibodies to respiratory syncytial virusPILKINGTON GLENN R·Filed 2008·Application pending·0 cites
- 1164US8207311B2Ovr115 antibody compositions and methods of usePILKINGTON GLENN·Filed 2004·Granted Jun 26, 2012·1 cites·46 claims
- 1264US2010209438A1OVR110 Antibody Compositions and Methods of UsePILKINGTON GLENN·Filed 2009·Application pending·0 cites
- 1356US2012263647A1Pro104 Antibody Compositions and Methods of UsePAPKOFF JACKIE·Filed 2011·Application pending·0 cites
- 1450US2013022539A1Ovr115 antibody compositions and methods of useDIADEXUS INC·Filed 2012·Application pending·0 cites
- 1545US2012329079A1Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer RiskSIMON IRIS·Filed 2012·Application pending·0 cites
- 1643US2009202472A1Molecules and chimeric molecules thereofAPOLLO LIFE SCIENCES LTD·Filed 2005·Application pending·0 cites
- 1743US2009142294A1Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposesAPOLLO LIFE SCIENCES LTD·Filed 2006·Application pending·0 cites
- 1841US2009175819A1Molecule and chimeric molecules thereofAPOLLO LIFE SCIENCES LTD·Filed 2006·Application pending·0 cites
- 1941US2009136490A1Ovr110 antibody compositions and methods for useDIADEXUS INC·Filed 2005·Application pending·0 cites
- 2041US2009232808A1Molecules and chimeric molecules thereofAPOLLO LIFE SCIENCES LTD·Filed 2006·Application pending·0 cites
- 2141US2009311247A1Molecules and chimeric molecules thereofAPOLLO LIFE SCIENCES LTD·Filed 2005·Application pending·0 cites
- 2240US2007292346A1Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer RiskFAN RONG·Filed 2005·Application pending·0 cites
- 2340US2009136444A1molecule and chimeric molecules thereofAPOLLO LIFE SCIENCES LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Glenn Pilkington files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →